Jianing Chen

Shanghai, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Evolutionary Trajectory of Radioresistance in Lung Cancer Brain Metastasis Organoids.

Evolutionary Trajectory of Radioresistance in Lung Cancer Brain Metastasis Organoids.

Journal: Biological procedures online
Published: March 14, 2026

The role of tumor metabolic reprogramming in acquired anti-PD-1/PD-L1 resistance.

The role of tumor metabolic reprogramming in acquired anti-PD-1/PD-L1 resistance.

Journal: Translational lung cancer research
Published: February 06, 2026

Stabilin-1+ lipid-associated macrophages promote lung adenocarcinoma liver metastasis and osimertinib resistance through impairing macrophage phagocytosis via SIRPα-CD47 axis.

Stabilin-1+ lipid-associated macrophages promote lung adenocarcinoma liver metastasis and osimertinib resistance through impairing macrophage phagocytosis via SIRPα-CD47 axis.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: November 01, 2025

A Rare Case of Long-Term Survival in Stage IIIB Lung Adenocarcinoma: an 9-Year Follow-Up.

A Rare Case of Long-Term Survival in Stage IIIB Lung Adenocarcinoma: an 9-Year Follow-Up.

Journal: Biological procedures online
Published: June 08, 2025

Aumolertinib in combination with Lastet in the first-line treatment of EGFR-mutated, locally advanced or metastatic non-small cell lung cancer (EVOLUTION): protocol for a single-arm, phase II clinical trial.

Aumolertinib in combination with Lastet in the first-line treatment of EGFR-mutated, locally advanced or metastatic non-small cell lung cancer (EVOLUTION): protocol for a single-arm, phase II clinical trial.

Journal: BMJ open
Published: April 30, 2025

A web-based prediction model for brain metastasis in non-small cell lung cancer patients.

A web-based prediction model for brain metastasis in non-small cell lung cancer patients.

Journal: Discover oncology
Published: March 18, 2025

PMS2 amplification contributes brain metastasis from lung cancer.

PMS2 amplification contributes brain metastasis from lung cancer.

Journal: Biological procedures online
Published: March 01, 2024

A retrospective study of first-line therapy and subsequent pyrotinib treatment in advanced lung adenocarcinoma with HER2 mutations.

A retrospective study of first-line therapy and subsequent pyrotinib treatment in advanced lung adenocarcinoma with HER2 mutations.

Journal: Cancer medicine
Published: February 27, 2024

Mutational signatures of synchronous and metachronous brain metastases from lung adenocarcinoma.

Mutational signatures of synchronous and metachronous brain metastases from lung adenocarcinoma.

Journal: Experimental hematology & oncology
Published: November 15, 2022

Generation of 99.8 fs, 25 kW Peak-Power, Dispersion-Managed Pulses Directly from an Yb-Doped Figure-of-9 Fiber Laser.

Generation of 99.8 fs, 25 kW Peak-Power, Dispersion-Managed Pulses Directly from an Yb-Doped Figure-of-9 Fiber Laser.

Journal: Materials (Basel, Switzerland)
Published: August 22, 2022

Pulmonary adverse events associated with hypertension in non-small cell lung cancer patients receiving PD-1/PD-L1 inhibitors.

Pulmonary adverse events associated with hypertension in non-small cell lung cancer patients receiving PD-1/PD-L1 inhibitors.

Journal: Frontiers in pharmacology
Published: May 15, 2022

Cerebrospinal fluid-derived circulating tumor DNA is more comprehensive than plasma in NSCLC patients with leptomeningeal metastases regardless of extracranial evolution.

Cerebrospinal fluid-derived circulating tumor DNA is more comprehensive than plasma in NSCLC patients with leptomeningeal metastases regardless of extracranial evolution.

Journal: Heliyon
Published: March 11, 2022
Showing 1-12 of 18

Last Updated: 09/26/2026